Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

SBTS0003087_069 - Letter from Dr Peter Forsyth to Dr S E Watters - 09 Feb 2006

Published on: 02 August, 2023

SBTS0003087_070 - Letter from Dr Peter Forsyth to Dr M Mack - 25 Jan 2006

Published on: 02 August, 2023

SBTS0003087_077 - Letter from Dr Peter Forsyth to Dr A McKellar - 13 Dec 2005

Published on: 02 August, 2023

SBTS0003087_078 - Letter from Dr Peter Forsyth to Dr J Tittmar - 30 Nov 2005

Published on: 02 August, 2023

SBTS0003087_081 - Letter from Dr Peter Forsyth to Dr A MacPherson - 30 Nov 2005

Published on: 02 August, 2023

SBTS0003087_082 - Assessment of the risk of vCJD due to receipt of blood from a donor - 01 Nov 2005

Published on: 02 August, 2023

SBTS0003200_130 - Chronological Summary of events 10 December 2002.pdf

Published on: 02 August, 2023

SBTS0003629_071 - Letter from Dr M Turner to Mr Sullivan - 12 May 1997

Published on: 02 August, 2023

SBTS0003629_073 - Minutes of the Fibrin Sealant Clinical Trials Strategy Group meeting - 30 Apr 1997

Published on: 02 August, 2023

SBTS0003649_041 - Creutzfeldt-Jakob Disease after Liver Transplantation - 10 May 1996

Published on: 02 August, 2023

SBTS0003658_013 - SEAC Q&A briefing on blood and blood products - 06 Nov 1997

Published on: 02 August, 2023

SBTS0003661_039 - Policy for Prevention of Batch Cross Contamination with Infective Prions - 21 Jan 1998

Published on: 02 August, 2023

SBTS0003661_044 - Fax from Dr J Metters - 26 Feb 1998

Published on: 02 August, 2023

SBTS0003661_048 - Letter from Sir Christopher Mallaby to Members of Primary Immunodeficiency Association - 04 Mar 1998

Published on: 02 August, 2023

SBTS0003998_090 - New-Variant Creutzfeldt-Jakob Disease The Risk of Transmission by Blood Transfusion - 01 Jan 1996

Published on: 02 August, 2023

SBTS0004436_122 - Note on CJD Incidents Panel Teleconference to discuss SNBTS issue - 01 Feb 2011

Published on: 02 August, 2023

SBTS0004436_128 - Summary of positive PMCA blood test for vCJD result for CJD Incident - 15 Jan 2010

Published on: 02 August, 2023

SBTS0004436_129 - Letter from David Pryer to Professor Marc Turner - 21 Jan 2011

Published on: 02 August, 2023

DHNI0000033_048 - Annex I Sourcing of Plasma and Urinary Derived Medicinal Products - 14 Mar 2003

Published on: 02 August, 2023

DHSC0020789_134 - Background and outcome of risk assessment

Published on: 02 August, 2023

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 3265
  • Page 3266
  • Page 3267
  • Page 3268
  • Current page 3269
  • Page 3270
  • Page 3271
  • Page 3272
  • Page 3273
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.